This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Sodium arsenite
- DrugBank Accession Number
- DB18508
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for Sodium arsenite (DB18508)
- Weight
- Average: 129.909
Monoisotopic: 129.901194 - Chemical Formula
- AsNaO2
- Synonyms
- Arsenenous acid, sodium salt (1:1)
- Arsenious acid, monosodium salt
- Arsenious acid, sodium salt
- Sodium (meta)arsenite
- Sodium arsenenite
- Sodium dioxoarsenate
- Sodium meta arsenite
- Sodium meta-arsenite
- Sodium metaarsenite
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 48OVY2OC72
- CAS number
- 7784-46-5
- InChI Key
- PTLRDCMBXHILCL-UHFFFAOYSA-M
- InChI
- InChI=1S/AsHO2.Na/c2-1-3;/h(H,2,3);/q;+1/p-1
- IUPAC Name
- sodium oxoarsinite
- SMILES
- [Na+].[O-][As]=O
References
- General References
- Not Available
- External Links
- KEGG Compound
- C11906
- ChemSpider
- 22980
- ChEBI
- 29678
- ChEMBL
- CHEMBL1909078
- Wikipedia
- Sodium_arsenite
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 1 Terminated Treatment Non-Small Cell Lung Cancer, Small Cell Lung Cancer / Platinum Responsive Malignancies 1 Not Available Recruiting Not Available Cardiotoxicity / Evaluation Studies / Reactions Adverse 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -0.14 Chemaxon pKa (Strongest Acidic) 2.08 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 40.13 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 2.89 m3·mol-1 Chemaxon Polarizability 3.95 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at September 27, 2023 20:18 / Updated at September 28, 2023 05:41